DN
David Nierengarten Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
51
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
88.9%
Neutral
5.6%
Negative
5.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Technology
Consumer Discretionary
Residential Construction
Restaurants
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Solar
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $95 |
39%
upside
| 1 | -3.4% |
0
%
| 3 Mar ‘26 20 hours ago |
|
|
|
Outperform
Maintained
| $65 |
139%
upside
| 1 | -16% |
0
%
| 25 Feb ‘26 6 days ago |
|
|
|
Outperform
Maintained
| $53 |
17%
upside
| 2 | +24% |
0
%
| 25 Feb ‘26 6 days ago |
|
|
|
Outperform
Reiterated
| $20 |
48%
upside
| 3 | +8.8% |
0
%
| 24 Feb ‘26 7 days ago |
|
|
|
Underperform
Initiated
| $110 |
1%
downside
| 1 | +16% |
0
%
| 24 Feb ‘26 7 days ago |
|
|
|
Outperform
Maintained
| $88 |
37%
upside
| 1 | -4.9% |
0
%
| 17 Feb ‘26 14 days ago |
|
|
|
Outperform
Reiterated
| $11 |
152%
upside
| 1 | +18% |
0
%
| 10 Feb ‘26 21 days ago |
|
|
|
Outperform
Reiterated
| $11 |
113%
upside
| 1 | +32% |
0
%
| 30 Jan ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $55 |
48%
upside
| 1 | -6.7% |
0
%
| 21 Jan ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $31 |
44%
upside
| 1 | +73% |
0
%
| 15 Jan ‘26 1 month ago |
|
|
|
Neutral
Reiterated
| $18 |
35%
upside
| 1 | – |
–
| 15 Jan ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $1,000 |
34%
upside
| 1 | +6.1% |
0
%
| 14 Jan ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $30 |
67%
upside
| 1 | +2.8% |
0
%
| 13 Jan ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $5.50 | – | 1 | +6.5% |
0
%
| 16 Dec ‘25 2 months ago |
|
|
|
Outperform
Reiterated
| $25 |
157%
upside
| 1 | -1.4% |
0
%
| 11 Dec ‘25 2 months ago |
|